Research progress on the structural and anti-colorectal malignant tumor properties of Shikonin
- PMID: 39792404
- DOI: 10.4103/jcrt.jcrt_933_24
Research progress on the structural and anti-colorectal malignant tumor properties of Shikonin
Abstract
Colorectal cancer is the third most prevalent malignant tumor worldwide. Despite the advancements in surgical procedures and treatment options, CRC remains a considerable cause of cancer-related mortality. Shikonin is a naphthoquinone compound that exhibits multiple biological activities, including anti-inflammatory and anti-tumor effects as well as wound healing promotion. Recently, Shikonin has been increasingly used in basic research on colorectal malignant tumors. Therefore, we explored the mechanisms of action and structural improvements of Shikonin in colorectal cancer through a literature review to provide valuable insights for the advancement of research and development of related pharmaceuticals.
Copyright © 2025 Journal of Cancer Research and Therapeutics.
Similar articles
-
Shikonin induces colorectal carcinoma cells apoptosis and autophagy by targeting galectin-1/JNK signaling axis.Int J Biol Sci. 2020 Jan 1;16(1):147-161. doi: 10.7150/ijbs.36955. eCollection 2020. Int J Biol Sci. 2020. PMID: 31892852 Free PMC article.
-
Pharmacological Effects of Shikonin and Its Potential in Skin Repair: A Review.Molecules. 2023 Dec 5;28(24):7950. doi: 10.3390/molecules28247950. Molecules. 2023. PMID: 38138440 Free PMC article. Review.
-
Recent advances in shikonin for the treatment of immune-related diseases: Anti-inflammatory and immunomodulatory mechanisms.Biomed Pharmacother. 2023 Sep;165:115138. doi: 10.1016/j.biopha.2023.115138. Epub 2023 Jul 14. Biomed Pharmacother. 2023. PMID: 37454591 Review.
-
Shikonin in breast cancer treatment: a comprehensive review of molecular pathways and innovative strategies.J Pharm Pharmacol. 2024 Aug 2;76(8):967-982. doi: 10.1093/jpp/rgae041. J Pharm Pharmacol. 2024. PMID: 38652046 Review.
-
SIRT2 mediated antitumor effects of shikonin on metastatic colorectal cancer.Eur J Pharmacol. 2017 Feb 15;797:1-8. doi: 10.1016/j.ejphar.2017.01.008. Epub 2017 Jan 12. Eur J Pharmacol. 2017. PMID: 28088387
References
-
- Zhou W, Jiang Hda G, Peng Y, Li SS. Comparative study on enantiomeric excess of main akannin/shikonin derivatives isolated from the roots of three endemic Boraginaceae plants in China. Biomed Chromatogr 2011;25:1067–75.
-
- Guo C, He J, Song X, Tan L, Wang M, Jiang P, et al. Pharmacological properties and derivatives of shikonin-A review in recent years. Pharmacol Res 2019;149:104463.
-
- Shukla YN, Srivastava A, Singh SC, Kumar S. New naphthoquinones from Arnebia hispidissima roots. Planta Med 2001;67:575–7.
-
- Islam M, Anvarbatcha R, Kunnathodi F, Athar MT, Tariq M. Quinacrine enhances the efficacy of cisplatin by increasing apoptosis and modulating cancer survival proteins in a colorectal cancer cell line. J Cancer Res Ther 2023;19:1988–97.
-
- Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-κB in biology and targeted therapy:New insights and translational implications. Signal Transduct Target Ther 2024;9:53.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical